Project/Area Number |
21591096
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Neurology
|
Research Institution | Sapporo Medical University |
Principal Investigator |
HISAHARA Shin 札幌医科大学, 医学部, 助教 (80336403)
|
Co-Investigator(Kenkyū-buntansha) |
SHIMOHAMA Shun 札幌医科大学, 医学部, 教授 (60235687)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 神経分子病態学 / ヒストン脱アセチル化酵素 / SIRTファミリー / パーキンソン病 / 酸化ストレス / 細胞死 |
Research Abstract |
We now have investigating the function of histone deacetylase SIRT(sirtuin). To explore preventive effect against cell death, we have performed cell viability assay in PC12 and SHSY5Y cells with administration of hydrogen peroxide(H2O2) and 6-hydroxydopamine(6-OHDA). Administration of resveratrol, an activator of SIRT, and overexpression of SIRT1 resulted in significant inhibition of oxidative stress-induced cell death. We also found that overexpression of SIRT1H355Y, a dominant-negative SIRT1, showed partial inhibition of cell death. These results indicate that SIRT1 promotes cellular viability via deacetylase activity-dependent and -independent mechanisms.
|